FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal CancerBusiness Wire • 05/16/24
Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual MeetingBusiness Wire • 04/24/24
Top 2 Health Care Stocks Which Could Rescue Your Portfolio This Month - Agenus (NASDAQ:AGEN), MultiPlan (NYSE:MPLN)Benzinga • 04/23/24
Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal CancerBusiness Wire • 04/12/24
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?The Motley Fool • 04/03/24
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial ReportBusiness Wire • 02/29/24
Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular DesignPRNewsWire • 02/15/24